telehealth services new jersey compounded glp-1 receptor agonist weight loss TrimRX Trinity Meds GLP-1 Program 2026:
Description
Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
These therapies are widely used in hospitals, specialty clinics, and outpatient settings, with growing applications in chronic weight management and cardiovascular risk reduction
PMID: 50 ThangaveluTLydenEShivaswamyV
Gorgojo-Martinez JJ, Mezquita-Raya P, Carretero-Gomez J, Castro A, Cebrian-Cuenca A, de Torres-Sanchez A, et al
Semaglutide for the treatment of obesity
PMID: 38302593
